Money
Filter News
Found 63,153 articles
-
PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005
10/14/2019
PPF Group, the majority owner of SOTIO, invests $6.5 million as part of MaveriX Oncology’s $20 million Series A financing round.
-
Nonprofit CureDuchenne Launches Biobank to Fuel Research for Duchenne Muscular Dystrophy
10/12/2019
UCI and RUCDR Infinite Biologics partner in establishing an important resource for translational medicine that is accessible to researchers worldwide.
-
Boston-based Ginkgo Bioworks calls itself “the organism company,” but what that means it uses microorganisms that it engineers across a broad range of markets. These engineered organisms churn out a wide variety of products. And the company has been on a frenzy of fundraising recently.
-
As the $63 billion acquisition of Allergan by Chicago-based AbbVie slowly churns through the Federal Trade Commission (FTC) process, the company continues to make the news. Here’s a look.
-
In September, House Speaker Nancy Pelosi unveiled a plan to lower prescription drug prices covered by government-funded plans that include tying those medications to an International Pricing Index – a move the pharmaceutical industry opposes wholeheartedly.
-
GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
-
Xoran Receives Multi-Million Dollar SBIR Grant Funding from the NIH with additional matching funds from external investors, Decathlon Capital Partners
10/10/2019
The award is matched with an additional $4M investment by private firm, Decathlon Capital Partners.
-
Vir Biotechnology Announces Pricing of Initial Public Offering
10/10/2019
Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.
-
Oncore Pharma Signs a Multi-Year Agreement Valued at $61.8 Million
10/10/2019
Oncore Pharma Inc., a life sciences company specializing in blood-based biomarker tests for early cancer detection, announced today that it has signed a multi-year agreement with BodyCheck NL valued at $61.8 million.
-
Humana Expands Partnership with Accolade
10/10/2019
Accolade and Humana Inc. (NYSE: HUM) announced today an expansion of their existing partnership that includes a $20 million strategic investment from Humana
-
CINDE Announces: Edwards Lifesciences Invests $100 million to Expand its Operations in Costa Rica
10/10/2019
Edwards Lifesciences Corporation, a world leader in innovations for structural heart disease and critical care monitoring aimed at patients, expanded its presence in Costa Rica with a $100 million investment and the addition of 500 new jobs by the end of 2020.
-
SimplyVital Health, Inc. Awarded Competitive Grant from the National Science Foundation for its HIPAA Compatible Blockchain Protocol
10/10/2019
Graphene is a breakthrough in block propagation technology that requires a fraction of network resources, improving the performance of the blockchain while lowering its costs.
-
Immutep Receives A$2.5 Million R&D Tax Incentive from French Government
10/10/2019
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce that it has received a €1,568,399 (~ A$2,546,929) research and development (R&D) tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme (CIR).
-
Soliton Announces $6.25 Million Private Placement
10/10/2019
Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has entered into definitive agreements with certain institutional and accredited investors to raise aggregate gross proceeds of approximately $6.25 million
-
Myra Medical, A Shifamed Portfolio Company, Closes $3M In Seed Financing
10/10/2019
Company is innovating next-generation treatment for moderate to advanced glaucoma
-
SCYNEXIS to Strengthen its Balance Sheet with Non-Dilutive Funding Through the New Jersey Economic Development Authority Net Operating Loss and R&D Tax Credits Program
10/10/2019
SCYNEXIS, Inc. has received notification from the State of New Jersey of its available unused net operating losses (NOLs) and R&D tax credits that can be sold under the New Jersey Economic Development Authority's (NJEDA) Technology Business Tax Certificate Transfer (NOL) program.
-
Future Meat Technologies Raises $14 Million in Series A Funding, Announces Pilot Production Facility
10/10/2019
Israeli startup is commercializing cultured meat through a distributive, GMO-free production platform
-
Ginkgo Bioworks Announces the Ferment Consortium, a $350 Million Investment Vehicle to Disrupt Established Markets with New Synthetic Biology Companies
10/10/2019
New investment vehicle to support the launch of companies with capital, network of strategic partners, and access to Ginkgo's platform for cell programming
-
Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma
10/10/2019
Mustang Bio, Inc. congratulated City of Hope, a world-renowned independent cancer research and treatment center, on its receipt of $4.1 million in grant awards for a clinical trial of MB-101 in combination with nivolumab and ipilimumab in patients with recurrent malignant glioma.
-
Delpor to Tackle Opioid Use Disorder with $5.7 Million NIH HEAL Grant Award for the Development of a Once-Yearly Naltrexone Therapy to Prevent Relapses
10/10/2019
Company to expand the use of its PROZOR implant technology by building on the success with its lead antipsychotic program